Sign in

CIK 0001082554 · Large accelerated filer

UNITED THERAPEUTICS Corp

Sign in to watch
Ticker
UTHR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
521984749
Phone
3016089292
Business address
1000 SPRING ST, SILVER SPRING, MD, 20910
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$342,898,837
in 74 filings, $342.1M under 10b5-1 plans

Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −480 $594.74 $285K 22,333
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −500 $595.91 $298K 21,833
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −204 $596.74 $122K 21,629
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −240 $597.72 $143K 21,389
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −200 $598.83 $120K 21,189
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −790 $599.82 $474K 20,399
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −212 $601.43 $128K 20,187
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −417 $602.53 $251K 19,770
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −103 $603.69 $62K 19,667
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −770 $604.64 $466K 18,897
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Sale 10b5-1 −21 $606.53 $13K 18,876
2026-03-30 EDGEMOND JAMES CFO AND TREASURER Option exercise · Stock Option 10b5-1 −10,000 132,500
2026-03-30 CAUSEY CHRISTOPHER Director Option exercise 10b5-1 +1,300 $119.76 $156K 5,490
2026-03-30 CAUSEY CHRISTOPHER Director Sale 10b5-1 −1,300 $604.64 $786K 4,190
2026-03-30 CAUSEY CHRISTOPHER Director Option exercise · Stock Option 10b5-1 −1,300 5,000
2026-03-30 ROTHBLATT MARTINE A Chairperson & CEO Option exercise 10b5-1 +9,500 $146.03 $1.4M 50,013
2026-03-30 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −80 $581.74 $47K 49,933
2026-03-30 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −160 $583.40 $93K 49,773
2026-03-30 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −86 $584.80 $50K 49,687
2026-03-30 ROTHBLATT MARTINE A Chairperson & CEO Sale 10b5-1 −354 $586.07 $207K 49,333

Page 136 of 171 · 3,408 trades